Publicacións nas que colabora con Arancha Cebr Aranda (2)

2024

  1. Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z)

    British Journal of Cancer

  2. Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

    British Journal of Cancer, Vol. 130, Núm. 8, pp. 1402-1413